Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline.

Key Takeaways for GI Nurses

• Informed consent discussions must explicitly include sedation-specific risks and benefits, not just procedural consent — nurses involved in consent processes or patient education should ensure this is documented and communicated clearly.
• High-risk patients (e.g., significant comorbidities, obesity, obstructive sleep apnea, advanced age) require tailored pre-assessment, individualized sedation plans, and more intensive periprocedural monitoring — this has direct staffing and equipment implications for pre-procedure screening and recovery area vigilance.
• Sedation planning should scale with procedural complexity: a routine diagnostic gastroscopy does not require the same level of monitoring as a prolonged ERCP or therapeutic colonoscopy, allowing nursing teams to stratify resources appropriately.
• Patients on GLP-1 receptor agonists (e.g., semaglutide, liraglutide) need individualized sedation management — nurses should flag this medication class during pre-assessment given concerns around delayed gastric emptying and aspiration risk.

Clinical Relevance

This updated ESGE/ESGENA guideline reinforces the nurse's central role in the sedation pathway, from pre-procedure risk stratification through to recovery. The emphasis on formalized pre-assessment for high-risk patients means nursing staff conducting intake screening need clear, standardized tools to identify patients who require escalated monitoring — whether that's continuous capnography, additional staffing, or physician-administered sedation rather than nurse-administered moderate sedation. Units should review their current pre-assessment checklists against this guidance to ensure risk factors such as BMI extremes, cardiopulmonary disease, and airway concerns are systematically captured before the patient reaches the procedure room.

The guideline's call to match sedation intensity and monitoring to procedural complexity has practical workflow implications. Endoscopy units may need to revisit scheduling and resource allocation so that longer, more invasive procedures (ERCP, EUS, complex polypectomy) are matched with appropriate nurse-to-patient ratios, monitoring equipment, and recovery time, while simpler diagnostic cases maintain efficient throughput without unnecessary over-monitoring. This risk-and-complexity-based approach supports both patient safety and sensible resource use, which is particularly relevant in high-volume units under productivity pressure.

The specific mention of GLP-1 receptor agonists reflects a rapidly evolving area of practice given the surge in prescriptions for weight management and diabetes. Nurses should be proactive in asking about these medications during pre-assessment calls or on arrival, since delayed gastric emptying can increase regurgitation and aspiration risk during sedation. Because the recommendation calls for individualized management rather than a blanket protocol (such as mandatory fasting extension or liquid-only diets), units should develop internal guidance or decision pathways — potentially in collaboration with anesthesia colleagues — so frontline nurses aren't making these judgment calls in isolation. This is also an area ripe for in-service education, as practice is still evolving and evidence certainty remains low.

Bottom Line

For busy GI nurses, the core message is that sedation safety hinges on individualized, risk-adjusted care: consent conversations must cover sedation specifically, pre-assessment and monitoring intensity should flex with both patient risk factors (including GLP-1 receptor agonist use) and procedural complexity, and units should ensure standardized tools and protocols are in place so these judgments are consistent and well-supported rather than left to ad hoc clinical discretion.